641585356	641585356	CD	B-NP	O
|	|	NN	I-NP	O
RAHCMC	RAHCMC	NN	I-NP	O
|	|	NN	I-NP	O
31915100	31915100	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3341031	3341031	CD	B-NP	O
|	|	CC	I-NP	O
10/10/2005	10/10/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
UTI	UTI	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/3/2005	2/3/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/17/2005	6/17/2005	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
FRAYNE	FRAYNE	NN	B-NP	O
,	,	,	O	O
MALCOLM	MALCOLM	NN	B-NP	O
378-95-34-0	378-95-34-0	CD	I-NP	O
Rich	Rich	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
10/4/05	10/4/05	CD	B-NP	O
AT	AT	NN	I-NP	O
11	11	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
THOEN	THOEN	NNP	B-NP	O
,	,	,	O	O
MITCH	MITCH	NNP	B-NP	O
LONG	LONG	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Skilled	Skille	VBN	B-VP	O
Nursing	Nurse	VBG	B-VP	O
Facility	Facility	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
EC	EC	NNP	B-NP	B-cell_type
ASA	ASA	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
BACITRACIN	BACITRACIN	NN	I-NP	O
TOPICAL	TOPICAL	NN	I-NP	O
TP	TP	NN	I-NP	O
BID	BID	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
Apply	Apply	RB	B-ADVP	O
to	to	TO	B-PP	O
affected	affect	VBN	B-NP	O
areas	area	NNS	I-NP	O
on	on	IN	B-PP	O
face	face	NN	B-NP	O
COLACE	COLACE	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
HYDRALAZINE	HYDRALAZINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QID	QID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	NN	B-NP	B-protein
25	25	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
MG	MG	NNP	I-NP	O
GLUCONATE	GLUCONATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
MAGNESIUM	MAGNESIUM	NNP	I-NP	O
GLUCONATE	GLUCONATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
orally	orally	RB	B-ADVP	O
-RRB-	-RRB-	HYPH	B-NP	O
QD	QD	NN	I-NP	O
-	-	HYPH	O	O
>	>	SYM	B-NP	O
Mg-scales	Mg-scale	NNS	B-NP	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
and	and	CC	O	O
magnesium	magnesium	NN	B-NP	O
doses	dose	NNS	I-NP	O
must	must	MD	B-VP	O
be	be	VB	I-VP	O
individualized	individualize	VBN	I-VP	O
for	for	IN	B-PP	O
patients	patient	NNS	B-NP	O
who	who	WP	B-NP	O
have	have	VBP	B-VP	O
:	:	:	O	O
-	-	:	O	O
a	a	DT	B-NP	O
serum	serum	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
or	or	CC	O	O
equal	equal	JJ	B-ADJP	O
to	to	TO	B-PP	O
2.0	2.0	CD	B-NP	O
mg/dL	mg/dL	NN	I-NP	O
;	;	:	O	O
or	or	CC	O	O
-	-	:	O	O
a	a	DT	B-NP	O
serum	serum	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
or	or	CC	O	O
equal	equal	JJ	B-ADJP	O
to	to	TO	B-PP	O
1.5	1.5	CD	B-NP	O
mg/dL	mg/dL	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
of	of	IN	B-PP	O
0.5	0.5	CD	B-NP	O
mg/dL	mg/dL	NN	I-NP	O
within	within	IN	B-PP	O
24	24	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

Call	Call	NN	B-NP	O
HO	HO	NN	I-NP	O
if	if	IN	B-SBAR	O
Mg	Mg	NN	B-NP	O
level	level	NN	I-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
0.8	0.8	CD	I-NP	O
If	If	IN	B-SBAR	O
Mg	Mg	NN	B-NP	O
level	level	NN	I-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
gm	gm	NN	I-NP	O
Mg	Mg	NN	I-NP	O
Gluconate	Gluconate	NN	I-NP	O
orally	orally	RB	B-ADVP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	O
If	If	IN	B-SBAR	O
Mg	Mg	NN	B-NP	O
level	level	NN	I-NP	O
is	be	VBZ	B-VP	O
1.0-1	1.0-1	CD	B-NP	O
.5	.5	CD	I-NP	O
,	,	,	O	O
then	then	RB	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
gm	gm	NN	I-NP	O
Mg	Mg	NN	I-NP	O
Gluconate	Gluconate	NN	I-NP	O
orally	orally	RB	B-ADVP	O
If	If	IN	B-SBAR	O
Mg	Mg	NN	B-NP	O
level	level	NN	I-NP	O
is	be	VBZ	B-VP	O
1.6-1	1.6-1	CD	B-NP	O
.9	.9	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
1	1	CD	B-NP	O
gm	gm	NN	I-NP	O
Mg	Mg	NN	I-NP	O
Gluconate	Gluconate	NN	I-NP	O
orally	orally	RB	B-ADVP	O
If	If	IN	B-SBAR	O
Mg	Mg	NN	B-NP	O
level	level	NN	I-NP	O
is	be	VBZ	B-VP	O
2.0-2	2.0-2	CD	B-NP	O
.5	.5	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
Do	Do	VBP	B-VP	O
Not	Not	RB	I-VP	O
administer	administer	VB	I-VP	O
Mg	Mg	NN	B-NP	O
Gluconate	Gluconate	NN	I-NP	O
Call	Call	NN	I-NP	O
HO	HO	NN	I-NP	O
if	if	IN	B-SBAR	O
Mg	Mg	NN	B-NP	O
level	level	NN	I-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
2.5	2.5	CD	B-NP	O
MG	MG	NNP	I-NP	O
OXIDE	OXIDE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
MAGNESIUM	MAGNESIUM	NNP	I-NP	O
OXIDE	OXIDE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
HEAVY	HEAVY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
420	420	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
LOPRESSOR	LOPRESSOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QID	QID	NNP	I-NP	O
HOLD	HOLD	NNP	I-NP	O
IF	IF	NNP	I-NP	O
:	:	:	O	O
HR	HR	NN	B-NP	B-protein
<	<	SYM	O	I-protein
55	55	CD	B-NP	I-protein
,	,	,	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
100	100	CD	B-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
Take	Take	VB	B-VP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

BACTROBAN	BACTROBAN	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
MUPIROCIN	MUPIROCIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
TOPICAL	TOPICAL	NN	I-NP	O
TP	TP	NN	I-NP	O
BID	BID	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
Apply	Apply	RB	B-ADVP	O
to	to	TO	B-PP	O
ulceration	ulceration	NN	B-NP	O
on	on	IN	B-PP	O
left	left	JJ	B-NP	B-DNA
forehead	forehead	NN	I-NP	I-DNA
NORVASC	NORVASC	NNP	I-NP	I-DNA
-LRB-	-LRB-	NNP	I-NP	I-DNA
AMLODIPINE	AMLODIPINE	NNP	I-NP	I-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
10	10	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QD	QD	NNP	I-NP	I-DNA
Starting	Starting	NNP	I-NP	I-DNA
Today	Today	NNP	I-NP	I-DNA
May	May	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

ALTACE	ALTACE	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
RAMIPRIL	RAMIPRIL	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/12/05	10/12/05	CD	B-NP	O
by	by	IN	B-PP	O
KARPIAK	KARPIAK	NN	B-NP	B-protein
,	,	,	O	O
ADRIAN	ADRIAN	NN	B-NP	O
I	I	NNP	I-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
66491864	66491864	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
RAMIPRIL	RAMIPRIL	NN	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NN	I-NP	O
CHLORIDE	CHLORIDE	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
LOVENOX	LOVENOX	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ENOXAPARIN	ENOXAPARIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
30	30	CD	I-NP	O
MG	MG	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QD	QD	NNP	I-NP	O
ARICEPT	ARICEPT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DONEPEZIL	DONEPEZIL	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	I-NP	O
250	250	CD	B-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q24H	Q24H	NN	I-NP	O
X	X	NN	I-NP	O
1	1	CD	I-NP	O
doses	dose	VBZ	B-VP	O
Starting	Starting	NNP	B-NP	O
Today	Today	NNP	I-NP	O
May	May	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
give	give	VB	B-VP	O
one	one	CD	B-NP	O
more	more	JJR	I-NP	O
dose	dose	NN	I-NP	O
-	-	HYPH	O	O
September	September	NNP	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Administer	Administer	NNP	I-NP	O
iron	iron	NN	I-NP	O
products	product	NNS	I-NP	O
a	a	DT	B-NP	O
minimum	minimum	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
before	before	IN	B-PP	O
or	or	CC	I-PP	O
after	after	IN	I-PP	O
a	a	DT	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
or	or	CC	I-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
dose	dose	NN	I-NP	O
dose	dose	NN	I-NP	O
If	If	IN	B-SBAR	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
cycle	cycle	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hold	hold	VBP	B-VP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
before	before	IN	B-PP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
Take	Take	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
hours	hour	NNS	I-NP	I-protein
before	before	IN	B-PP	O
or	or	CC	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
dairy	dairy	NN	B-NP	O
products	product	NNS	I-NP	O
.	.	.	O	O

SEROQUEL	SEROQUEL	NN	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
QUETIAPINE	QUETIAPINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
LANTUS	LANTUS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
14	14	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QD	QD	NNP	I-NP	O
NOVOLOG	NOVOLOG	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
ASPART	ASPART	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
subcutaneously	subcutaneously	RB	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
SC	SC	NN	I-NP	B-protein
AC	AC	NN	I-NP	I-protein
If	If	IN	B-SBAR	I-protein
BS	BS	NNP	B-NP	I-protein
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
125	125	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
125-150	125-150	CD	B-NP	O
,	,	,	O	O
then	then	RB	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
151-200	151-200	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
201-250	201-250	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
251-300	251-300	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
301-350	301-350	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
351-400	351-400	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	B-protein
Call	Call	NN	I-NP	I-protein
HO	HO	NN	I-NP	I-protein
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
400	400	CD	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dermatology	Dermatology	NNP	B-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Jerrold	Jerrold	NNP	I-NP	O
Irick	Irick	NNP	I-NP	O
728-724-8552	728-724-8552	CD	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NNP	B-NP	O
:	:	:	O	O
Penicillins	Penicillins	NNP	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
dizziness	dizziness	NN	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
UTI	UTI	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
cad	cad	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hx	hx	NN	I-NP	O
mi	mi	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
H/O	H/O	NN	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hx	hx	NN	I-NP	O
chf	chf	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
H/O	H/O	NN	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hx	hx	NN	I-NP	O
cva	cva	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
H/O	H/O	NN	I-NP	O
cerebrovascular	cerebrovascular	JJ	I-NP	O
accident	accident	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
reflux	reflux	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
gastroesophageal	gastroesophageal	JJ	I-NP	O
reflux	reflux	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
L	L	NN	I-NP	O
nephrectomy	nephrectomy	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
nephrectomy	nephrectomy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
?	?	.	O	O

meningioma	meningioma	NN	B-NP	O
on	on	IN	B-PP	O
scan	scan	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
?	?	.	O	O

meningioma	meningioma	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
gallstones	gallstone	NNS	I-NP	O
-LRB-	-LRB-	VBP	B-VP	O
gallstones	gallstone	NNS	B-NP	O
-RRB-	-RRB-	WDT	B-NP	O
h/o	h/o	NN	I-NP	O
multiple	multiple	JJ	I-NP	O
falls	fall	NNS	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
H/O	H/O	NN	I-NP	O
falls	fall	VBZ	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
NIDDM	NIDDM	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
diabetes	diabetes	NN	I-NP	I-protein
mellitus	mellitus	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
dementia	dementia	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
?	?	.	O	O

alzheimer	alzheimer	NN	B-NP	O
's	's	POS	B-NP	O
since	since	IN	I-NP	O
11/1	11/1	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
dementia	dementia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
na	na	NN	B-NP	O
OTHER	OTHER	NNP	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
skin	skin	NN	I-NP	O
bx	bx	NN	I-NP	O
10/24/05	10/24/05	CD	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
82	82	CD	B-NP	O
yo	yo	NN	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
altered	alter	VBN	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
and	and	CC	I-NP	O
dizziness	dizziness	NN	I-NP	O
.	.	.	O	O

82	82	CD	B-NP	O
yo	yo	NN	I-NP	O
female	female	JJ	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
AD	AD	NN	B-NP	O
,	,	,	O	O
NIDDM	NIDDM	NN	B-NP	B-protein
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
dizziness	dizziness	NN	B-NP	O
and	and	CC	O	O
altered	alter	VBD	B-VP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
X	X	SYM	B-NP	O
1	1	CD	I-NP	O
week	week	NN	I-NP	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
marked	mark	VBN	I-VP	O
pyuria	pyuria	NN	B-NP	O
c/w	c/w	NN	I-NP	O
UTI	UTI	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	NNP	B-NP	O
:	:	:	O	O
Afebrile	Afebrile	NNP	B-NP	O
72124/58	72124/58	CD	B-NP	O
18	18	CD	I-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
ra	ra	NN	I-NP	O
,	,	,	O	O
got	get	VBD	B-VP	O
IVF	IVF	NN	B-NP	B-protein
and	and	CC	O	O
levoflox	levoflox	NN	B-NP	B-protein
500mg	500mg	CD	I-NP	I-protein
X	X	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
.	.	.	O	O

PMH	PMH	NN	B-NP	O
:	:	:	O	O
Dementia	Dementia	NN	B-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
Cerebellar	Cerebellar	NNP	B-NP	O
CVA	CVA	NNP	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
Nephrectomy	Nephrectomy	NNP	I-NP	O
,	,	,	O	O
R	R	NNP	B-NP	O
frontal	frontal	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
meningioma	meningioma	NN	I-NP	O
PE	PE	NN	I-NP	O
:	:	:	O	O
mental	mental	JJ	B-ADJP	O
:	:	:	O	O
Alert	Alert	NN	B-NP	O
,	,	,	O	O
pleasant	pleasant	NN	B-NP	O
,	,	,	O	O
disoriented	disoriented	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
forgetful	forgetful	JJ	I-ADJP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
R	R	NN	B-NP	O
periorbital	periorbital	JJ	I-NP	O
erythema	erythema	NN	I-NP	O
and	and	CC	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

R	R	NN	B-NP	B-protein
nares	nare	VBZ	B-VP	O
ulceration	ulceration	NN	B-NP	O
and	and	CC	O	O
oozing	ooze	VBG	B-VP	O
CVS	CVS	NN	B-NP	O
:	:	:	O	O
JVP	JVP	NN	B-NP	O
flat	flat	NN	I-NP	O
,	,	,	O	O
rrr	rrr	JJ	B-NP	O
PULM	PULM	NN	I-NP	O
:	:	:	O	O
CTA/bl	CTA/bl	NN	B-NP	O
ABD	ABD	NN	I-NP	O
:	:	:	O	O
Soft	Soft	JJ	B-NP	O
,	,	,	I-NP	O
non-tender	non-tender	JJ	I-NP	O
Studies	Study	NNS	I-NP	O
:	:	:	O	O
CXR	CXR	NN	B-NP	B-protein
:	:	:	O	O
Clear	Clear	NNP	B-NP	O
CT	CT	NNP	I-NP	O
Brain	Brain	NNP	I-NP	O
:	:	:	O	O
Old	Old	NNP	B-NP	O
cerebellar	cerebellar	JJ	I-NP	O
infarct	infarct	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
ocute	ocute	JJ	I-NP	O
process	process	NN	I-NP	O
.	.	.	O	O

Problems	Problem	NNS	B-NP	O
:	:	:	O	O
**	**	SYM	B-NP	O
Altered	Altered	JJ	B-NP	O
mental	mental	JJ	I-NP	O
status/dizziness	status/dizziness	NN	I-NP	O
-	-	HYPH	B-VP	O
likely	likely	RB	B-ADJP	O
2/2	2/2	CD	B-NP	O
to	to	TO	B-PP	O
UTI	UTI	NN	B-NP	B-DNA
and	and	CC	I-NP	O
volume	volume	NN	I-NP	O
depletion	depletion	NN	I-NP	O
.	.	.	O	O

Treat	Treat	JJ	B-NP	O
UTI	UTI	NN	I-NP	O
with	with	IN	B-PP	O
levoflox	levoflox	NN	B-NP	O
.	.	.	O	O

Replete	Replete	JJ	B-NP	O
volume	volume	NN	I-NP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
saline	saline	NN	I-NP	O
.	.	.	O	O

Levo	Levo	RB	B-ADVP	O
renally	renally	RB	B-VP	O
dosed	dose	VBN	I-VP	O
.	.	.	O	O

**	**	SYM	O	O
Renal	Renal	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
-	-	HYPH	B-NP	O
chronic	chronic	JJ	I-NP	O
2/2	2/2	CD	I-NP	O
nephrectomy	nephrectomy	NN	I-NP	O
.	.	.	O	O

Renally	Renally	RB	B-NP	O
dose	dose	NN	I-NP	O
all	all	DT	B-NP	O
meds	med	NNS	I-NP	O
.	.	.	O	O

**	**	SYM	O	O
R	R	NN	B-NP	O
periorbital	periorbital	JJ	I-NP	O
erythema/edema	erythema/edema	NN	I-NP	O
and	and	CC	I-NP	O
R	R	NN	I-NP	B-protein
nares	nare	VBZ	B-VP	O
ulceration	ulceration	NN	B-NP	O
-	-	HYPH	B-ADJP	O
?	?	.	O	O

BCC	BCC	NN	B-NP	O
.	.	.	O	O

Equivocal	Equivocal	JJ	B-NP	O
bx	bx	NN	I-NP	O
last	last	JJ	B-NP	O
year	year	NN	I-NP	O
.	.	.	O	O

Seen	Seen	NN	B-NP	O
by	by	IN	B-PP	O
derm	derm	NN	B-NP	O
-	-	HYPH	B-NP	O
path	path	NN	I-NP	O
w/unclear	w/unclear	JJ	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
.	.	.	O	O

Will	Will	MD	O	O
need	need	VBP	O	O
Moh	Moh	NNP	B-NP	O
's	's	POS	B-NP	O
microsurgery	microsurgery	NN	I-NP	O
and	and	CC	O	O
then	then	RB	B-NP	O
plastics	plastic	NNS	B-NP	O
reconstruction	reconstruction	NN	I-NP	O
.	.	.	O	O

Outpatient	Outpatient	JJ	B-NP	O
derm	derm	NN	I-NP	O
appointment	appointment	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
.	.	.	O	O

Superimposed	Superimpose	VBN	B-NP	O
cellulitis	cellulitis	NN	I-NP	O
.	.	.	O	O

Adequate	Adequate	JJ	B-NP	O
coverage	coverage	NN	I-NP	O
with	with	IN	B-PP	O
levoflox	levoflox	NN	B-NP	O
for	for	IN	B-PP	O
7	7	CD	B-NP	O
day	day	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
febrile	febrile	NN	B-NP	O
will	will	MD	B-VP	O
add	add	VB	I-VP	O
vancomycin	vancomycin	NN	B-NP	O
.	.	.	O	O

**	**	SYM	O	O
Diabetes	Diabetes	NN	B-NP	O
-	-	HYPH	I-NP	O
Lantus	Lantus	NN	I-NP	O
+	+	SYM	I-NP	O
novolog	novolog	NN	I-NP	O
SS	SS	NN	I-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
.	.	.	O	O

**	**	SYM	B-NP	B-protein
FEN	FEN	NN	I-NP	I-protein
-	-	HYPH	O	O
hyponatremia	hyponatremia	NN	B-NP	O
2/2	2/2	CD	I-NP	O
to	to	TO	B-PP	O
hypovolemia	hypovolemia	NN	B-NP	O
.	.	.	O	O

NS	NS	NN	B-NP	O
resuccitation	resuccitation	NN	I-NP	O
.	.	.	O	O

Full	Full	NNP	B-NP	O
Code	Code	NNP	I-NP	O
ADDITIONAL	ADDITIONAL	NNP	I-NP	O
COMMENTS	COMMENTS	NNP	I-NP	O
:	:	:	O	O
DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
dermatology	dermatology	NN	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Casid	Casid	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
for	for	IN	B-PP	O
Moh	Moh	NNP	B-NP	O
's	's	POS	B-NP	O
microsurgery	microsurgery	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
RESETAR	RESETAR	NNP	B-NP	O
,	,	,	O	O
CARSON	CARSON	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CV16	CV16	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10/4/05	10/4/05	CD	I-NP	O
@	@	NN	I-NP	O
10	10	CD	I-NP	O
:	:	:	O	O
41	41	CD	B-NP	O
AM	AM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

